HPV-RELATED SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom immune cells unleashed against multiple cancers in pioneering trial
Disease control OngoingThis early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
New Triple-Threat attack on HPV-Linked throat cancer enters testing
Disease control OngoingThis study is testing whether adding a vaccine that targets the HPV virus to standard cancer treatments (chemotherapy, radiation, and an immunotherapy drug) can better control a specific type of throat cancer. It is for adults newly diagnosed with intermediate-risk, HPV-16 positi…
Matched conditions: HPV-RELATED SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Mar 06, 2026 15:38 UTC